Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (221-230 of 297) with videos related to

Pageof 30
Sort By:
The European Respiratory Journal|July 22, 2021
Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosisAmisha V Barochia, Maryann Kaler, Nargues Weir, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|October 4, 2021
Inhaled Nitric Oxide via High-Flow Nasal Cannula in Patients with Acute Respiratory Failure Related to COVID-19Abhimanyu Chandel, Saloni Patolia, Kareem Ahmad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 22, 2022
Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunctionKatrina Bazemore, Nitipong Permpalung, Joby Mathew, et al.
Pulmonary Circulation|January 4, 2024
Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosisSteven D Nathan, Benham Tehrani, Qiong Zhao, et al.
The Lancet. Respiratory Medicine|August 22, 2020
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Steven D Nathan, Wim A Wuyts, et al.
Annals of the American Thoracic Society|April 12, 2021
Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary FibrosisJean Pastre, Scott D Barnett, Inga Ksovreli, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2012
Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-βRobert Matthew Kottmann, Ajit A Kulkarni, Katie A Smolnycki, et al.
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2024
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical TrialMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Pageof 30

Showing results (221-230 of 297) with videos related to

Sort By:
Pageof 30
The European Respiratory Journal|July 22, 2021
Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosisAmisha V Barochia, Maryann Kaler, Nargues Weir, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|October 4, 2021
Inhaled Nitric Oxide via High-Flow Nasal Cannula in Patients with Acute Respiratory Failure Related to COVID-19Abhimanyu Chandel, Saloni Patolia, Kareem Ahmad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 22, 2022
Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunctionKatrina Bazemore, Nitipong Permpalung, Joby Mathew, et al.
Pulmonary Circulation|January 4, 2024
Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosisSteven D Nathan, Benham Tehrani, Qiong Zhao, et al.
The Lancet. Respiratory Medicine|August 22, 2020
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Steven D Nathan, Wim A Wuyts, et al.
Annals of the American Thoracic Society|April 12, 2021
Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary FibrosisJean Pastre, Scott D Barnett, Inga Ksovreli, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2012
Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-βRobert Matthew Kottmann, Ajit A Kulkarni, Katie A Smolnycki, et al.
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2024
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical TrialMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Pageof 30